Šalis: Armėnija
kalba: anglų
Šaltinis: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
ascorbic acid
Arpimed LLC
A11GA01
ascorbic acid
250mg
tablets
(10/1x10/) blister
OTC
Registered
2015-04-30
SUMMARY OF PRODUCT CHARACTERISTICS VITAMIN C 250 AND 500MG TABLETS 1.1BRAND NAME – Vitamin C 1.2GENERIC NAME -Ascorbic Acid 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 500mg of ascorbic acid. Each tablet contains 250mg of ascorbic acid. For excipients, see 6.1. 3. PHARMACEUTICAL FORM Round biconvex white tablets scored on one side; odorless. (Vitamin C, 250mg tablets). Slightly violet round biconvex tablets of white color; odorless. (Vitamin C, 500mg tablets). 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prevention and treatment of scurvy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration: Oral Dose Adults (including the elderly) and children over 6 years: _ _ _Prophylactic:_25 – 75 mg daily. Note:Thеsе unit dosages formsаre unsuitable for prophylactic use. _Therapeutic:_Not less than 250mg daily in divided doses._ _ Children under 6 years: These unit dosages formsare unsuitable for children under 6 years. 4.3 CONTRAINDICATIONS Hypersensitivity to ascorbic acid. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Increased intake of ascorbic acid over a prolonged period may result in an increase in renal clearance of ascorbic acid and deficiency may result if it is withdrawn rapidly. Large doses are associated with the formation of renal calcium oxalate calculi. Ascorbic acid should be given with care to patients with hyperoxaluria. The administration of therapeutic doses may interfere with Clinistix test for glucosuria giving a false negative result. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Concomitant administration of aluminium-containing antacids may increase urinaryaluminium elimination. Concurrent administration of antacids and ascorbic acid is not recommended, especially in patients with renal insufficiency. Concurrent use of ascorbic acid with barbiturates or primidone may increase the urinary excretion of ascorbic acid. Concurrent use with cellulose sodium phosphate may result in metabolism of ascorbic acid to oxalate. Concur Perskaitykite visą dokumentą